Age-related neuronal degeneration: Complementary roles of nucleotide excision repair and transcription-coupled repair in preventing neuropathology

PLoS Genetics

Volumn 7, Issue 12, 2011, Pages

  Jaarsma, Dick ^a   van der Pluijm, Ingrid ^a   de Waard, Monique C ^a   Haasdijk, Elize D ^a   Brandt, Renata ^a   Vermeij, Marcel ^a   Rijksen, Yvonne ^a   Maas, Alex ^a   van Steeg, Harry ^b   Hoeijmakers, Jan H J ^a   van der Horst, Gijsbertus T J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLYCINE; MYELIN; PROTEIN P53; ERCC2 PROTEIN, MOUSE; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XPA PROTEIN, MOUSE;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CELL LOSS; CELL SURVIVAL; CELLULAR DISTRIBUTION; COCKAYNE SYNDROME; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; EMBRYO; EXCISION REPAIR; FEMALE; MALE; MICROGLIA; MOUSE; MYELIN DEFICIENCY; MYELINATED NERVE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; POINT MUTATION; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS; TRANSCRIPTION COUPLED REPAIR; WHITE MATTER; XERODERMA PIGMENTOSUM; AGING; ANIMAL; DISEASE MODEL; DISORDERS OF DNA SYNTHESIS AND REPAIR; GENETICS; HUMAN; LEUKOENCEPHALOPATHY; METABOLISM; MYELIN SHEATH; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MUS;

AGING; ANIMALS; ASTROCYTES; COCKAYNE SYNDROME; DISEASE MODELS, ANIMAL; DNA REPAIR; DNA REPAIR-DEFICIENCY DISORDERS; HUMANS; LEUKOENCEPHALOPATHIES; MICE; MYELIN SHEATH; NERVE DEGENERATION; NEURONS; POINT MUTATION; XERODERMA PIGMENTOSUM; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84855288980     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002405     Document Type: Article

References (85)

1. Hoeijmakers JH, (2009) DNA damage, aging, and cancer. N Engl J Med 361: 1475-1485.
2. Nouspikel T, (2007) DNA repair in differentiated cells: some new answers to old questions. Neuroscience 145: 1213-1221.
3. Rass U, Ahel I, West SC, (2007) Defective DNA repair and neurodegenerative disease. Cell 130: 991-1004.
4. Friedberg EC, Aguilera A, Gellert M, Hanawalt PC, Hays JB, et al. (2006) DNA repair: from molecular mechanism to human disease. DNA Repair (Amst) 5: 986-996.
5. McKinnon PJ, (2009) DNA repair deficiency and neurological disease. Nat Rev Neurosci 10: 100-112.
6. Hoeijmakers JH, (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374.
7. Hanawalt PC, Spivak G, (2008) Transcription-coupled DNA repair: two decades of progress and surprises. Nat Rev Mol Cell Biol 9: 958-970.
8. Cleaver JE, Lam ET, Revet I, (2009) Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet 10: 756-768.
9. Stevnsner T, Muftuoglu M, Aamann MD, Bohr VA, (2008) The role of Cockayne Syndrome group B (CSB) protein in base excision repair and aging. Mech Ageing Dev 129: 441-448.
10. Muftuoglu M, de Souza-Pinto NC, Dogan A, Aamann M, Stevnsner T, et al. (2009) Cockayne Syndrome Group B Protein Stimulates Repair of Formamidopyrimidines by NEIL1 DNA Glycosylase. J Biol Chem 284: 9270-9279.
11. Soufir N, Ged C, Bourillon A, Austerlitz F, Chemin C, et al. (2010) A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol 130: 1537-1542.
12. Khan SG, Oh KS, Emmert S, Imoto K, Tamura D, et al. (2009) XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms. DNA Repair (Amst) 8: 114-125.
13. Fousteri M, Vermeulen W, van Zeeland AA, Mullenders LH, (2006) Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol Cell 23: 471-482.
14. Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, et al. (2007) Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 145: 1388-1396.
15. Nance MA, Berry SA, (1992) Cockayne syndrome: review of 140 cases. Am J Med Genet 42: 68-84.
16. Laugel V, Dalloz C, Durand M, Sauvanaud F, Kristensen U, et al. (2010) Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Hum Mutat 31: 113-126.
17. Mimaki T, Itoh N, Abe J, Tagawa T, Sato K, et al. (1986) Neurological manifestations in xeroderma pigmentosum. Ann Neurol 20: 70-75.
18. Kraemer KH, Lee MM, Scotto J, (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123: 241-250.
19. Anttinen A, Koulu L, Nikoskelainen E, Portin R, Kurki T, et al. (2008) Neurological symptoms and natural course of xeroderma pigmentosum. Brain 131: 1979-1989.
20. de Waard H, de Wit J, Andressoo JO, van Oostrom CT, Riis B, et al. (2004) Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage. Mol Cell Biol 24: 7941-7948.
21. Nardo T, Oneda R, Spivak G, Vaz B, Mortier L, et al. (2009) A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. Proc Natl Acad Sci U S A.
22. Brooks PJ, Cheng TF, Cooper L, (2008) Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage? DNA Repair (Amst) 7: 834-848.
23. Lake RJ, Geyko A, Hemashettar G, Zhao Y, Fan HY, (2010) UV-induced association of the CSB remodeling protein with chromatin requires ATP-dependent relief of N-terminal autorepression. Mol Cell 37: 235-246.
24. Scharer OD, (2008) Hot topics in DNA repair: the molecular basis for different disease states caused by mutations in TFIIH and XPG. DNA Repair (Amst) 7: 339-344.
25. Ito S, Kuraoka I, Chymkowitch P, Compe E, Takedachi A, et al. (2007) XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol Cell 26: 231-243.
26. Shiomi N, Mori M, Kito S, Harada YN, Tanaka K, et al. (2005) Severe growth retardation and short life span of double-mutant mice lacking Xpa and exon 15 of Xpg. DNA Repair (Amst) 4: 351-357.
27. Lehmann AR, (2008) XPD structure reveals its secrets. DNA Repair (Amst) 7: 1912-1915.
28. Andressoo JO, Jans J, de Wit J, Coin F, Hoogstraten D, et al. (2006) Rescue of progeria in trichothiodystrophy by homozygous lethal Xpd alleles. PLoS Biol 4: e322 doi:10.1371/journal.pbio.0040322.
29. Andressoo JO, Weeda G, de Wit J, Mitchell JR, Beems RB, et al. (2009) An Xpb mouse model for combined xeroderma pigmentosum and cockayne syndrome reveals progeroid features upon further attenuation of DNA repair. Mol Cell Biol 29: 1276-1290.
30. Coin F, Oksenych V, Egly JM, (2007) Distinct roles for the XPB/p52 and XPD/p44 subcomplexes of TFIIH in damaged DNA opening during nucleotide excision repair. Mol Cell 26: 245-256.
31. Stefanini M, Botta E, Lanzafame M, Orioli D, (2010) Trichothiodystrophy: from basic mechanisms to clinical implications. DNA Repair (Amst) 9: 2-10.
32. Scharer OD, (2008) XPG: its products and biological roles. Adv Exp Med Biol 637: 83-92.
33. Andrews AD, Barrett SF, Robbins JH, (1976) Relation of D.N.A. repair processes to pathological ageing of the nervous system in xeroderma pigmentosum. Lancet 1: 1318-1320.
34. Maeda T, Sato K, Minami H, Taguchi H, Yoshikawa K, (1995) Chronological difference in walking impairment among Japanese group A xeroderma pigmentosum (XP-A) patients with various combinations of mutation sites. Clin Genet 48: 225-231.
35. Itoh M, Hayashi M, Shioda K, Minagawa M, Isa F, et al. (1999) Neurodegeneration in hereditary nucleotide repair disorders. Brain Dev 21: 326-333.
36. Mimaki T, Nitta M, Saijo M, Tachi N, Minami R, et al. (1996) Truncated XPA protein detected in atypical group A xeroderma pigmentosum. Acta Paediatr 85: 511-513.
37. Hashimoto S, Suga T, Kudo E, Ihn H, Uchino M, et al. (2008) Adult-onset neurological degeneration in a patient with Cockayne syndrome and a null mutation in the CSB gene. J Invest Dermatol 128: 1597-1599.
38. Rapin I, Weidenheim K, Lindenbaum Y, Rosenbaum P, Merchant SN, et al. (2006) Cockayne syndrome in adults: review with clinical and pathologic study of a new case. J Child Neurol 21: 991-1006.
39. Spivak G, Hanawalt PC, (2006) Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair (Amst) 5: 13-22.
40. Niedernhofer LJ, (2008) Nucleotide excision repair deficient mouse models and neurological disease. DNA Repair (Amst) 7: 1180-1189.
41. de Vries A, van Oostrom CT, Hofhuis FM, Dortant PM, Berg RJ, et al. (1995) Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 377: 169-173.
42. Nakane H, Takeuchi S, Yuba S, Saijo M, Nakatsu Y, et al. (1995) High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 377: 165-168.
43. Melis JP, Wijnhoven SW, Beems RB, Roodbergen M, van den Berg J, et al. (2008) Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res 68: 1347-1353.
44. Nakane H, Hirota S, Brooks PJ, Nakabeppu Y, Nakatsu Y, et al. (2008) Impaired spermatogenesis and elevated spontaneous tumorigenesis in xeroderma pigmentosum group A gene (Xpa)-deficient mice. DNA Repair (Amst) 7: 1938-1950.
45. van der Horst GT, van Steeg H, Berg RJ, van Gool AJ, de Wit J, et al. (1997) Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 89: 425-435.
46. van der Horst GT, Meira L, Gorgels TG, de Wit J, Velasco-Miguel S, et al. (2002) UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice. DNA Repair (Amst) 1: 143-157.
47. Cheo DL, Ruven HJ, Meira LB, Hammer RE, Burns DK, et al. (1997) Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat Res 374: 1-9.
48. Gorgels TG, van der Pluijm I, Brandt RM, Garinis GA, van Steeg H, et al. (2007) Retinal degeneration and ionizing radiation hypersensitivity in a mouse model for Cockayne syndrome. Mol Cell Biol 27: 1433-1441.
49. Andressoo JO, Mitchell JR, de Wit J, Hoogstraten D, Volker M, et al. (2006) An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria. Cancer Cell 10: 121-132.
50. de Boer J, de Wit J, van Steeg H, Berg RJ, Morreau H, et al. (1998) A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol Cell 1: 981-990.
51. de Boer J, van Steeg H, Berg RJ, Garssen J, de Wit J, et al. (1999) Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition. Cancer Res 59: 3489-3494.
52. Wijnhoven SW, Beems RB, Roodbergen M, van den Berg J, Lohman PH, et al. (2005) Accelerated aging pathology in ad libitum fed Xpd(TTD) mice is accompanied by features suggestive of caloric restriction. DNA Repair (Amst) 4: 1314-1324.
53. Dolle ME, Busuttil RA, Garcia AM, Wijnhoven S, van Drunen E, et al. (2006) Increased genomic instability is not a prerequisite for shortened lifespan in DNA repair deficient mice. Mutat Res 596: 22-35.
54. de Waard H, de Wit J, Gorgels TG, van den Aardweg G, Andressoo JO, et al. (2003) Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair (Amst) 2: 13-25.
55. de Waard H, Sonneveld E, de Wit J, Esveldt-van Lange R, Hoeijmakers JH, et al. (2008) Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts. DNA Repair (Amst) 7: 1659-1669.
56. Wijnhoven SW, Hoogervorst EM, de Waard H, van der Horst GT, van Steeg H, (2007) Tissue specific mutagenic and carcinogenic responses in NER defective mouse models. Mutat Res 614: 77-94.
57. Levine AJ, Hu W, Feng Z, (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027-1036.
58. Rotshenker S, Reichert F, Gitik M, Haklai R, Elad-Sfadia G, et al. (2008) Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia 56: 1607-1613.
59. Streit WJ, Walter SA, Pennell NA, (1999) Reactive microgliosis. Prog Neurobiol 57: 563-581.
60. Iwaki T, Iwaki A, Tateishi J, Sakaki Y, Goldman JE, (1993) Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol 143: 487-495.
61. Li H, Yuan J, (1999) Deciphering the pathways of life and death. Curr Opin Cell Biol 11: 261-266.
62. Murai M, Enokido Y, Inamura N, Yoshino M, Nakatsu Y, et al. (2001) Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes. Proc Natl Acad Sci U S A 98: 13379-13384.
63. van der Pluijm I, Garinis GA, Brandt RM, Gorgels TG, Wijnhoven SW, et al. (2007) Impaired genome maintenance suppresses the growth hormone-insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol 5: e2 doi:10.1371/journal.pbio.0050002.
64. Laposa RR, Huang EJ, Cleaver JE, (2007) Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice. Proc Natl Acad Sci U S A 104: 1389-1394.
65. Sakai K, Miyazaki J, (1997) A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun 237: 318-324.
66. Dragatsis I, Zeitlin S, (2000) CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain. Genesis 26: 133-135.
67. Fukui H, Diaz F, Garcia S, Moraes CT, (2007) Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 104: 14163-14168.
68. Holmes A, Yang RJ, Crawley JN, (2002) Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice. J Mol Neurosci 18: 151-165.
69. Fan F, Jin S, Amundson SA, Tong T, Fan W, et al. (2002) ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 21: 7488-7496.
70. Turchi L, Fareh M, Aberdam E, Kitajima S, Simpson F, et al. (2009) ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress. Cell Death Differ 16: 728-737.
71. Barski JJ, Dethleffsen K, Meyer M, (2000) Cre recombinase expression in cerebellar Purkinje cells. Genesis 28: 93-98.
72. Soffer D, Grotsky HW, Rapin I, Suzuki K, (1979) Cockayne syndrome: unusual neuropathological findings and review of the literature. Ann Neurol 6: 340-348.
73. Leech RW, Brumback RA, Miller RH, Otsuka F, Tarone RE, et al. (1985) Cockayne syndrome: clinicopathologic and tissue culture studies of affected siblings. J Neuropathol Exp Neurol 44: 507-519.
74. Roth KA, (2001) Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol 60: 829-838.
75. Guegan C, Przedborski S, (2003) Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest 111: 153-161.
76. Kohji T, Hayashi M, Shioda K, Minagawa M, Morimatsu Y, et al. (1998) Cerebellar neurodegeneration in human hereditary DNA repair disorders. Neurosci Lett 243: 133-136.
77. Enokido Y, Inamura N, Araki T, Satoh T, Nakane H, et al. (1997) Loss of the xeroderma pigmentosum group A gene (XPA) enhances apoptosis of cultured cerebellar neurons induced by UV but not by low-K+ medium. J Neurochem 69: 246-251.
78. Dzagnidze A, Katsarava Z, Makhalova J, Liedert B, Yoon MS, et al. (2007) Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J Neurosci 27: 9451-9457.
79. Brooks PJ, (2008) The 8,5′-cyclopurine-2′-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair (Amst) 7: 1168-1179.
80. Nouspikel T, (2008) Nucleotide excision repair and neurological diseases. DNA Repair (Amst) 7: 1155-1167.
81. de Waard MC, van der Pluijm I, Zuiderveen Borgesius N, Comley LH, Haasdijk ED, et al. (2010) Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice. Acta Neuropathol 120: 461-475.
82. Pastoriza-Gallego M, Armier J, Sarasin A, (2007) Transcription through 8-oxoguanine in DNA repair-proficient and Csb(-)/Ogg1(-) DNA repair-deficient mouse embryonic fibroblasts is dependent upon promoter strength and sequence context. Mutagenesis 22: 343-351.
83. Ng JM, Vrieling H, Sugasawa K, Ooms MP, Grootegoed JA, et al. (2002) Developmental defects and male sterility in mice lacking the ubiquitin-like DNA repair gene mHR23B. Mol Cell Biol 22: 1233-1245.
84. Kadotani H, Hirano T, Masugi M, Nakamura K, Nakao K, et al. (1996) Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. J Neurosci 16: 7859-7867.
85. Paxinos G, Franklin KBJ, (2001) The mouse brain in stereotaxic coordinates London Academic Press.